Patent · US Active

Compounds for the treatment of psychiatric or substance abuse disorders

US8030294B2 · kind B2 · utility

0Cited by
44References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 15, 2001
Grant dateOct 4, 2011
Priority date
Expiry dateMay 20, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods for treating or preventing psychiatric and substance abuse disorders, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, or adenosine-elevating compound to a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.